Venous thromboembolism prophylaxis in pregnant women with inflammatory bowel disease: evidence gaps and future directions from the KASID Guidelines Task Force Team

What To Know

This article reviews studies showing elevated VTE risk in pregnant and postpartum people with IBD, especially when disease is active, during hospitalization, or after cesarean delivery. Current guideline approaches generally favor selective, risk-stratified use of thromboprophylaxis rather than routine anticoagulation for all pregnant people with IBD.

The authors highlight that most data and guidelines are based on Western populations and argue for research to define population-specific absolute risks and to refine risk-based prophylaxis strategies in Asian settings.

The review summarizes safety considerations and clinical variables relevant to deciding on anticoagulation during pregnancy and postpartum, and it calls for future studies to fill evidence gaps and support tailored guideline recommendations.